Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Taxes: 2013-2024

Historic Current Taxes for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Dec 2024 value amounting to $9.7 million.

  • Amphastar Pharmaceuticals' Current Taxes rose 339.73% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 339.73%. This contributed to the annual value of $9.7 million for FY2024, which is 500.62% up from last year.
  • As of FY2024, Amphastar Pharmaceuticals' Current Taxes stood at $9.7 million, which was up 500.62% from $1.6 million recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Current Taxes registered a high of $9.7 million during FY2024, and its lowest value of $1.1 million during FY2020.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Current Taxes value was $4.6 million (recorded in 2022), while the average stood at $5.3 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Current Taxes spiked by 743.18% in 2021 and then crashed by 64.80% in 2023.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Current Taxes stood at $1.1 million in 2020, then surged by 743.18% to $9.1 million in 2021, then slumped by 49.66% to $4.6 million in 2022, then tumbled by 64.80% to $1.6 million in 2023, then soared by 500.62% to $9.7 million in 2024.